MEN 11420 clinical trials
Also written Nepadutant.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses MEN 11420 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilators source
Studies
Open first, then newest update. How each study uses MEN 11420 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding IntoleranceCompletedPhase 2Menarini GroupNCT01532518Written as NepadutantHow we know
- Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant ColicCompletedPhase 2Menarini GroupNCT01258153Written as Nepadutant oral solutionHow we know
- Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional TreatmentWithdrawnPhase 2Menarini GroupNCT01309009Written as Nepadutant oral solutionHow we know
- A Phase I Study to Evaluate the Oral Absorption of Nepadutant in InfantsCompletedPhase 1Menarini GroupNCT00655083Written as NepadutantHow we know
Codes
What other systems call MEN 11420 · ClinicalTrials.gg INT004009
- MeSH (NLM) C107754MEN 11420One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C107754 | MEN 11420 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.